Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hydreight Technologies Inc ( (TSE:NURS) ) just unveiled an update.
Hydreight Technologies has issued baseline fiscal 2026 revenue guidance of approximately $150 million and projected first-quarter 2026 revenue of $25 million to $28 million, reflecting growth from partnerships and pharmacy product lines launched in late 2025 and early 2026. The company expects to achieve an Adjusted EBITDA margin of about 15–17% on this revenue, supported by a largely fixed cost structure and existing infrastructure, and says it is adequately capitalized for its 2026 plan following a recent $15 million bought deal financing, positioning the business to scale transaction volumes without a material increase in operating expenses.
The most recent analyst rating on (TSE:NURS) stock is a Buy with a C$8.50 price target. To see the full list of analyst forecasts on Hydreight Technologies Inc stock, see the TSE:NURS Stock Forecast page.
More about Hydreight Technologies Inc
Hydreight Technologies Inc. is a U.S.-focused provider of compliant digital health infrastructure and on-demand healthcare services, building one of the largest mobile clinic networks in the country. The company operates a national regulatory, pharmacy, and technology platform that supports healthcare professionals and partners in delivering mobile and decentralized care.
Average Trading Volume: 152,297
Technical Sentiment Signal: Buy
Current Market Cap: C$195.8M
Find detailed analytics on NURS stock on TipRanks’ Stock Analysis page.